gynecologic oncology at asco 2022: tv pembro in first-line recurrent or metastatic cervical cancer
Published 2 years ago • 758 plays • Length 3:50Download video MP4
Download video MP3
Similar videos
-
0:46
gynecologic oncology at asco 2022: subgroup analysis of keynote-826
-
3:42
gynecologic oncology at asco 2022: athena–mono trial (rucaparib monotherapy) for ovarian cancer
-
2:44
gynecologic oncology at asco 2022: session highlights to share with your patients
-
9:00
gynecologic oncology at asco 2021: cervical cancer outback trial
-
3:18
gynecologic oncology at esmo congress 2021: trial study in cervical cancer
-
2:07
emerging therapies in gynecologic oncology at asco 2024
-
3:48
gynecologic oncology at esmo congress 2021: engot-cx8/gog-3024/innovatv 205 study
-
1:11
gyn onc at asco 2022: randomized phase iii trial on trabectedin in recurrent ovarian cancer
-
3:46
gynecologic oncology at asco 2018: open vs mis in cervical cancer, margul
-
7:57
gynecologic oncology highlights at asco20 #sgoatasco
-
5:44
mis and cervical cancer | shitanshu uppal, md, mbbs
-
0:30
treatment options for recurrent cervical cancer | premal thaker, md, ms | asco22 gyn cancer updates
-
3:21
gynecologic oncology at esmo congress 2021: phase 2 study in patients with r/m cervical cancer
-
1:26:55
gynecologic cancer treatment
-
3:11
gynecologic cancer studies: what to look for at asco 2022
-
3:58:57
ella t. grasso memorial gynecologic oncology conference
-
1:41
gyn onc at asco 2016: cervical cancer
-
26:47
2014 society of gynecologic oncology meeting: ovarian cancer